| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,090 |
1,073 |
$108K |
| 87631 |
|
82 |
82 |
$9K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
183 |
181 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
181 |
179 |
$6K |
| 80061 |
Lipid panel |
189 |
188 |
$2K |
| 87081 |
|
354 |
351 |
$2K |
| 80053 |
Comprehensive metabolic panel |
154 |
151 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
196 |
190 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
92 |
92 |
$1K |
| 80050 |
General health panel |
44 |
44 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
43 |
43 |
$1K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
145 |
145 |
$996.28 |
| 87660 |
|
45 |
42 |
$810.95 |
| 87480 |
|
44 |
41 |
$793.31 |
| 87510 |
|
44 |
41 |
$793.31 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
48 |
48 |
$420.58 |
| 82728 |
|
27 |
27 |
$331.09 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16 |
16 |
$205.24 |
| 83550 |
|
26 |
26 |
$204.77 |
| 85027 |
|
35 |
35 |
$197.30 |
| 83540 |
|
27 |
27 |
$157.71 |
| 83655 |
|
12 |
12 |
$130.72 |
| 87077 |
|
13 |
13 |
$104.66 |
| 81001 |
|
28 |
28 |
$76.65 |